1Y Zou, B Van Houten, N Farrell. Sequence specificity of DNA DNA interstrand crosslink formation by cisplatin and dinuclear platinum complexes[J]. Biochemistry,1994(33) :5404 - 5410
2Fokkema E,Groen HJ ,Helder MN,et al, JM216 - ,JM118- ,and cisplatin-induced cytotoxicity in relation to plstinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatin[J].Biochem Pharmacol,2002 Jun 1,63(11):1989- 1996
3S.Aklyama,Z. S. Chen,T. Sumizawa,et al. Resistance to cisplatin[J]. Anticancer Drug Des, 1999( 14):143- 151
4Liu J, Li C, Qu W, et al. Nitric oxide prodrugs and metallo-chemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation [ J ]. Mol Cancer Ther,2004,3(6) :709 - 714
5Z. S. Chen, M. Mutoh, T. Sumizawa, et al.An active efflux system for heavy metals in ciaplatin-resistant human KB carcinoma cells.Exp[J]. Cell Res,1998(240) :312- 320
6Pectasides D, Pectasides M, Farmakis D, et al. Oxaliplatin and irinotecan plus granulocyte-colony stimulating factor as third-line treatment in relapsed or cisplatin-refractory germ-cell tumor patients: a phase JI study[J].Eur Urol,2004,46(2) :216 - 221
7Gigante M,Toffoli G, Bertola A, et al. Radiosensitivity in maltidrug-resistant and cisplatin-resistant human carcinoma cell lines[J]. Am J Clin Oncol,2003,26(4) :e73 - 79
8RP Perez, Cellular and molecular determinants of cisplatin resistance[J]. Etlr J Cancer,1998(34) :1535 - 1542
9C Meijer,A Timmer.EG De Vries, et al.Role of metallothionein in cisplatin sensitivity of germ cell tumours[J]. Int J Cancer, 2000(85):777-781
10Lyakhovich A, Shekhar MP. RAD6B overexpression confers ch-emoresistance: RAD6 expression during cell cycle and its redistribution to chromatin during DNA damage-induced response[J]. Oncogene,2004,23(17):3097 - 3106
